In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Canagliflozin Drug Master File in Korea (Canagliflozin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Canagliflozin. The MFDS reviews the Canagliflozin KDMF as part of the drug registration process and uses the information provided in the Canagliflozin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Canagliflozin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Canagliflozin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Canagliflozin suppliers with KDMF on PharmaCompass.